Financial StabilityThe company reported approximately $47M in cash and cash equivalents at the end of 4Q24, which is believed to be sufficient to fund operations.

Bears Say

Pipeline DevelopmentUncertainties regarding the company's pipeline development and lack of meaningful catalysts contribute to the Neutral rating on LPTX.

Strategic PartnershipsThe company still needs to identify a partner to run the registrational Phase 3 study.

Leap Therapeutics News

3 Penny Stocks to Watch Now, 11/17/25

Leap Therapeutics, Amaze Holdings, and Aspire Biopharma Holdings are the 3 Penny Stocks to watch on November 17, 2025, based...

14d ago

AMZE

ASBP

Why Leap Therapeutics Stock (LPTX) Is in the News

U.S.-based Leap Therapeutics ($LPTX) shocked investors with a 368.6% surge in its stock on Wednesday. However, in pre-market...

18d ago

LPTX

3 Penny Stocks to Watch Now, 11/13/25

Leap Therapeutics, Amaze Holdings, and Salarius Pharmaceuticals are the 3 Penny Stocks to watch on November 13, 2025, based on TipRanks’...

18d ago

AMZE

LPTX

Three new option listings and three option delistings on November 13th

New option listings for November 13th include Chaince Digital Holdings Inc. (CD), Cypherpunk Technologies Inc. (CYPH), and Light...

18d ago

LNW

MFH

Leap Therapeutics to change name to ‘Cypherpunk Technologies,’ ticker to ‘CYPH’

Leap Therapeutics (LPTX) announced it will change its name to Cypherpunk Technologies and unveiled a digital asset treasury...

19d ago

LPTX

Leap Therapeutics Transforms into Cypherpunk Technologies

Leap Therapeutics ( ($LPTX) ) has released its Q3 earnings. Here is a breakdown of the information Leap...

18d ago

LPTX

Leap Therapeutics Enters $200M Equity Sales Agreement

Leap Therapeutics ( ($LPTX) ) just unveiled an update. On November 12, 2025, Cypherpunk Technologies Inc., formerly known...

18d ago

LPTX

Leap Therapeutics Rebrands and Acquires Zcash Tokens

Leap Therapeutics ( ($LPTX) ) just unveiled an update. On November 11, 2025, Cypherpunk Technologies Inc. announced a...

19d ago

LPTX

Leap Therapeutics Reveals Promising DeFianCe Study Results

Leap Therapeutics ( ($LPTX) ) just unveiled an announcement. On October 20, 2025, Leap Therapeutics announced the final...

1M ago

LPTX

Leap Therapeutics reports results from Phase 2 study of sirexatamab

Leap Therapeutics (LPTX) announced final results from Part B of the DeFianCe study, a Phase 2 study of...

1M ago

LPTX

Leap Therapeutics Raises $58.88M in Private Placement

Leap Therapeutics ( ($LPTX) ) has shared an update. On October 6, 2025, Leap Therapeutics entered into a...

2M ago

LPTX

Leap Therapeutics Announces $58.88M Private Placement

Leap Therapeutics ( ($LPTX) ) has shared an announcement. On October 6, 2025, Leap Therapeutics announced a $58.88...

2M ago

LPTX

Leap Therapeutics announces $58.88M private placement

Leap Therapeutics (LPTX) announced $58,888,888 in cash commitments for a private investment in public equity offering led by...

2M ago

LPTX

Leap Therapeutics Granted Extension by Nasdaq

The latest update is out from Leap Therapeutics ( ($LPTX) ). On March 12, 2025, Leap Therapeutics received...

3M ago

LPTX

LPTX FAQ

What was Leap Therapeutics’s price range in the past 12 months?

Currently, no data Available

What is Leap Therapeutics’s market cap?

Currently, no data Available

When is Leap Therapeutics’s upcoming earnings report date?

Leap Therapeutics’s upcoming earnings report date is Mar 23, 2026 which is in 112 days.

How were Leap Therapeutics’s earnings last quarter?

Leap Therapeutics released its earnings results on Nov 12, 2025. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.24 by $0.16.

Is Leap Therapeutics overvalued?

According to Wall Street analysts Leap Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Leap Therapeutics pay dividends?

Leap Therapeutics does not currently pay dividends.

What is Leap Therapeutics’s EPS estimate?

Leap Therapeutics’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Leap Therapeutics have?

Currently, no data Available

What happened to Leap Therapeutics’s price movement after its last earnings report?

Leap Therapeutics reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.24. Following the earnings report the stock price went up 365.909%.

Which hedge fund is a major shareholder of Leap Therapeutics?

Currently, no hedge funds are holding shares in LPTX